HRT Financial’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2M | Buy |
+31,370
| New | +$1.2M | 0.01% | 985 |
|
|
2024
Q4 | – | Sell |
-110,739
| Closed | -$4.53M | – | 2487 |
|
|
2024
Q3 | $4.53M | Buy |
+110,739
| New | +$4.53M | 0.02% | 470 |
|
|
2024
Q2 | – | Sell |
-180,021
| Closed | -$7.72M | – | 2366 |
|
|
2024
Q1 | $7.72M | Sell |
180,021
-336,563
| -65% | -$14.4M | 0.05% | 172 |
|
|
2023
Q4 | $19.1M | Buy |
516,584
+498,066
| +2,690% | +$18.5M | 0.14% | 76 |
|
|
2023
Q3 | $671K | Buy |
+18,518
| New | +$671K | 0.01% | 1106 |
|
|
2022
Q4 | – | Sell |
-85,793
| Closed | -$2.52M | – | 2524 |
|
|
2022
Q3 | $2.52M | Buy |
85,793
+73,983
| +626% | +$2.18M | 0.03% | 508 |
|
|
2022
Q2 | $642K | Buy |
11,810
+16
| +0.1% | +$870 | 0.01% | 1275 |
|
|
2022
Q1 | $642K | Buy |
+11,794
| New | +$642K | ﹤0.01% | 1300 |
|
|
2021
Q2 | – | Sell |
-58,177
| Closed | -$2.6M | – | 2974 |
|
|
2021
Q1 | $2.6M | Buy |
+58,177
| New | +$2.6M | 0.03% | 412 |
|
|
2019
Q2 | – | Sell |
-4,332
| Closed | -$226K | – | 788 |
|
|
2019
Q1 | $226K | Buy |
+4,332
| New | +$226K | 0.04% | 328 |
|
|
2018
Q4 | – | Sell |
-4,661
| Closed | -$234K | – | 629 |
|
|
2018
Q3 | $234K | Buy |
+4,661
| New | +$234K | 0.04% | 260 |
|
|
2017
Q2 | – | Sell |
-3,806
| Closed | -$200K | – | 100 |
|
|
2017
Q1 | $200K | Buy |
+3,806
| New | +$200K | 0.19% | 95 |
|